Expertise
Vaccines and Infectious Diseases

Ophthalmology

Clinical Neuroscience

Rare Disease

Cell and Gene Therapy

Additional Expertise

Hematology

Oncology

Maternal and Child Health

Medical Devices
Expertise Areas
Do you require a CRO with expertise in a number of therapeutic areas? And one with deep networks in site, investigator, patient advocacy and therapeutic communities?
Clinical Services
Biostatistics

Clinical Data Management

Clinical Research Services

Clinical Trial Management

Endpoint Solutions

Global Regulatory Affairs

Pharmacovigilance and Medical Monitoring

Real-world Evidence and Data

Patient Advocacy
Clinical Services
Emmes exists to provide its clients with the skill sets, technologies, and dedicated service required to manage clinical research studies. As a CRO we embrace your goals and manage your clinical research as if it were our own.
Emmes Story
Our People

Emmes Leaders

Clients

Emmes Locations

Emmes by the Numbers

Newsroom

Our Culture
Emmes Story
Welcome to Emmes, a global full service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation.
Careers

Careers
As a global company dedicated to advancing public health and biopharmaceutical science, we believe a career is so much more than just a job.
Veridix AI
Resource Center
Contact Us

Resource Center

The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity

1999

Journal Article

Authors:
Copley, J.; Staffeld, C.; Lindberg, J.; Baily, C.; Van Veldhuisen, P.

Location:
Buenes Aires, Argentina